SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000916002-97-000012
Filing Date
1997-03-10
Accepted
1997-03-10 00:00:00
Documents
3
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 10 TO SC 13D OF SEAFIELD CAPITAL CO SC 13D/A 19817
2 EXHIBIT 99.1 - AGREEMENT OF PAYMENT & SATISFACTION EX-99 10953
3 EXHIBIT 99.2 - PRESS RELEASE EX-99 1587
  Complete submission text file 0000916002-97-000012.txt   35146
Mailing Address 1775 MORIAH WOODS BLVD MEMPHIS TN 38117
Business Address 1775 MORIAH WOODS BLVD MEMPHIS TN 38117 9017617000
RESPONSE ONCOLOGY INC (Subject) CIK: 0000763098 (see all company filings)

IRS No.: 621212264 | State of Incorp.: TN | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37885 | Film No.: 97553149
SIC: 8093 Services-Specialty Outpatient Facilities, NEC

Mailing Address P.O. BOX 410949 2600 GRAND AVENUE, SUITE 500 KANSAS CITY MO 64141
Business Address 2600 GRAND AVE STE 500 P O BOX 410949 KANSAS CITY MO 64141 8168427000
SEAFIELD CAPITAL CORP (Filed by) CIK: 0000830158 (see all company filings)

IRS No.: 431039532 | State of Incorp.: MO | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories